Takahiro Kogo None;
Yuki Muraoka Bayer Yakuhin, Novartis Pharma KK, Code F (Financial Support), Bayer Yakuhin, Novartis Pharma KK, Canon, Santen Pharmaceutical, Senju Pharmaceutical, Code R (Recipient);
Masaharu Ishikura None;
Naomi Nishigori None;
Naoko Ueda Santen Pharmaceutical, Novartis Pharma KK, Chugai Pharmaceutical, Code R (Recipient);
Manabu Miyata Alcon Japan, Novartis Pharma KK, Santen Pharmaceutical, Code F (Financial Support), Santen Pharmaceutical, HOYA, Bayer Yakuhin, Senju Pharmaceutical, Kowa Pharmaceutical, Code R (Recipient);
Hiroshi Tamura Findex, Code F (Financial Support), Bayer Yakuhin, Novartis Pharma KK, Santen Pharmaceutical, SUNTORY, Otsuka Pharmaceutical, Code R (Recipient);
Masayuki Hata Novartis Pharma KK, Code F (Financial Support), Kyoto Drug Discovery & Development, Code P (Patent), Senju Pharmaceutical, Code R (Recipient);
Ayako Takahashi Bayer Yakuhin, Novartis Pharma, Santen Pharmaceutical, MSD, Code R (Recipient);
Masahiro Miyake Novartis Pharma KK, Code F (Financial Support), Novartis Pharma KK, Bayer Yakuhin, Kowa Pharmaceutical, Alcon Japan, AMO Japan, Santen Pharmaceutical, Senju Pharmaceutical, Johnson & Johnson K. K., Chugai Pharmaceutical, Code R (Recipient);
Akitaka Tsujikawa Senju Pharmaceutical,Bayer Yakuhin,Novartis Pharma,HOYA,Ellex,Allegan Japan,Eisai,Daiich-Sankyo,Chugai Pharmaceutical,MSD, Code C (Consultant/Contractor), Canon,Findex,Santen Pharmaceutical,Kowa Pharmaceutical,Pfizer,AMO Japan,Senju Pharmaceutical,Wakamoto Pharmaceutical,Alcon Japan,Novartis Pharma,Otsuka Pharmaceutical,Bayer Yakuhin,Nitten Pharmaceutical, Code F (Financial Support), Bayer Yakuhin,Senju Pharmaceutical,Novartis Pharma,Santen Pharmaceutical,Alcon Pharma,Alcon Japan,AbbVie GK,AMO Japan,Kowa Pharmaceutical,Canon,Otsuka Pharmaceutical,Wakamoto Pharmaceutical, Code R (Recipient)